Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease (PASADENA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03100149
Recruitment Status : Active, not recruiting
First Posted : April 4, 2017
Last Update Posted : April 26, 2019
Sponsor:
Collaborator:
Prothena Biosciences Limited
Information provided by (Responsible Party):
Hoffmann-La Roche